Ryoko Shimizu‐Hirota
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 4
- Cell Biology top 5%
- Proteoglycans and glycosaminoglycans research 6
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 5
- Reproductive Medicine top 5%
- Endometriosis Research and Treatment 7
- Immunology top 10%
- Reproductive System and Pregnancy 10
-
- Pregnancy and preeclampsia studies 3
-
- Fibroblast Growth Factor Research 3
-
- Reproductive Biology and Fertility 3
Ryoko Shimizu‐Hirota
35 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Immunology and Allergy 179
- Cell Biology 396
- Cancer Research 312
- Reproductive Medicine 170
- Immunology 372
Countries citing papers authored by Ryoko Shimizu‐Hirota
This map shows the geographic impact of Ryoko Shimizu‐Hirota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryoko Shimizu‐Hirota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryoko Shimizu‐Hirota more than expected).
Fields of papers citing papers by Ryoko Shimizu‐Hirota
This network shows the impact of papers produced by Ryoko Shimizu‐Hirota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryoko Shimizu‐Hirota. The network helps show where Ryoko Shimizu‐Hirota may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ryoko Shimizu‐Hirota, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 16 | |
| 4 | 2022 | 17 | |
| 5 | 2021 | 5 | |
| 6 | 2021 | 20 | |
| 7 | 2020 | 22 | |
| 8 | 2020 | 35 | |
| 9 | 2019 | 1 | |
| 10 | 2018 | 69 | |
| 11 | 2017 | 65 | |
| 12 | 2012 | 83 | |
| 13 | Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisitedbreakdown → | 2009 | 508 |
| 14 | 2005 | 20 | |
| 15 | 2004 | 41 | |
| 16 | 2003 | 33 | |
| 17 | 2002 | 14 | |
| 18 | 2002 | 27 | |
| 19 | 2001 | 50 | |
| 20 | 2001 | 25 |
About Ryoko Shimizu‐Hirota
Ryoko Shimizu‐Hirota is a scholar working on Reproductive Medicine, Immunology and Allergy and Obstetrics and Gynecology, having authored 35 papers that have together received 1.8k indexed citations. Recurring topics across this work include Reproductive System and Pregnancy (10 papers), Endometriosis Research and Treatment (7 papers), Proteoglycans and glycosaminoglycans research (6 papers), Protease and Inhibitor Mechanisms (5 papers), Cell Adhesion Molecules Research (4 papers), Pregnancy and preeclampsia studies (3 papers), Fibroblast Growth Factor Research (3 papers) and Reproductive Biology and Fertility (3 papers). The work is most often cited by research in Immunology and Allergy (179 citations), Cell Biology (396 citations) and Cancer Research (312 citations). Ryoko Shimizu‐Hirota has collaborated with scholars based in Japan, United States and Egypt. Frequent co-authors include Stephen J. Weiss, Farideh Sabeh, Hiroyuki Sasamura, Takao Saruta, Mizuo Mifune, Matsuhiko Hayashi, Yasunori Okada, Masayuki Shimoda, Emi Kobayashi and Hiroshi Itoh. Their work appears in journals such as Circulation, Journal of Clinical Investigation and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.